Sure, you've all heard of Uber and Lyft and Airbnb, and, sure, we expect them to go public at some point.
But timing is unclear for some of these well-known tech unicorns, and with the companies still carrying insane valuations in the private sector, it could be a while before they make it to market.
That said, there are a ton of companies that actually will go public this year, and you need to know about them.
Companies to begin trading last week include Yext(YEXT) - Get Report , Cadence Bancorp(CADE) - Get Report , Netshoes (NETS) , Azul(AZUL) - Get Report , Okta(OKTA) - Get Report and Warrior Met Coal(HCC) - Get Report , adding to the list of about 22 new listings (about $10.9 billion in funds raised) in the first quarter, according to a recent study from Ipreo, a research firm focused on private companies.
"The IPO market continued to plod along [in] Q1," Ipreo said in a March 31 report, noting a decline from 25 IPOs in the fourth quarter. Still, "Q1's figures mark a substantial increase over the comparable period last year, which saw just six issuers make public debuts for $582.0M."
The new issuers raised $10.9 billion in the first quarter.
Many, including enterprise software company Mulesoft (MULE) , which debuted on March 17, Bain Capital-backed Canada Goose(GOOS) - Get Report (March 16) and information technology solutions provider Presidio(PSDO) - Get Report (March 10), have been raving successes.
Ipreo doesn't see the market slowing down anytime soon, and as long as equities continue to trade around all-time highs, there is a good probability the IPO pipeline will continue to be robust.
With that said, TheStreet, and its sister publication The Deal, have compiled a list of some of the most anticipated IPOs of 2017, including everything from hot music startups to coal miners to airlines.
The list includes companies that have officially filed paperwork to start a U.S. listing as well as others that have not officially filed with the Securities and Exchange Commission but deserve some attention.
Here are the highlights:
*This list does not include the litany of biotech companies that have filed for IPOs, nor is it intended to be a comprehensive list of potential offerings in 2017.